Please login to the form below

Aptalis

This page shows the latest Aptalis news and features for those working in and with pharma, biotech and healthcare.

HIV prevention pill heads July CHMP recommendations

Other positive recommendations were given for Aptalis' Truberzi (eluxadoline) as a treatment for irritable bowel syndrome with diarrhoea, along with two biosimilar versions of Sanofi's clot-busting drug Lovenox (enoxaparin) -

Latest news

Actavis claims top UK generics spot with Auden Mckenzie buy

Other acquisitions in the last 12 months have included $25bn for Forest Laboratories, $2.9bn for Aptalis, a $1.6bn deal for Furiex Pharma and $675m for Durata.
Forest Labs agrees $1.46bn deal to buy Furiex

Forest chief executive Brent Saunders said the Furiex deal "is a natural extension of our GI business following our $2.9bn acquisition of Aptalis earlier this year," adding that eluxadoline would
Forest said to be interested in $3bn Aptalis acquisition

Forest said to be interested in $3bn Aptalis acquisition. Deal would give pharma company ownership of cystic fibrosis and gastrointestinal products. ... The Aptalis rumour also comes shortly after Forest itself was the subject of speculation about a
Par Pharma acquired by investment firm for $1.9bn

TPG has several major healthcare investments already, with stakes in firms such as Aptalis Pharma, Biomet, Immucor, IMS Health and Quintiles Transnational, and the acquisition of Par provides the company with

More from news
Approximately 2 fully matching, plus 3 partially matching documents found.

Latest Intelligence

Pharma deals during February 2014

The deal is expected to close mid 2014, pending approvals. The announcement came just after Forest completed its acquisition of Aptalis last month for $3bn and this month sold a number
Pharma deals during January 2014

Almost right to the end of the month, the big headline deal was that of Forest with its planned takeover of Aptalis. ... Aptalis itself was only formed in 2011 following the acquisition of Eurand by the Montreal based Axcan Pharma.
Deal Watch table for January 2014

4, 295. Aptalis/ Forest. Company acquisition. Acquiring sales turnover of $688m. 2, 900.

More from intelligence
Approximately 0 fully matching, plus 3 partially matching documents found.

Latest appointments

Intellia Therapeutics appoints Dr Moncef Slaoui and Dr Frank Verwiel

He has held numerous leadership roles including president and CEO of Aptalis Pharma prior to its acquisition by Forest Laboratories.
Lupin names chief corporate development officer

Lupin names chief corporate development officer. Theresa Stevens has experience at Novartis and Aptalis. ... Stevens joins the India-based pharma company from Aptalis Pharma, where she was chief corporate development officer for mergers and acquisitions,
Marino Garcia joins Synergy Pharmaceuticals

Marino Garcia joins Synergy Pharmaceuticals. He has experience in gastrointestinal market at Aptalis. ... Prior to his time at Aptalis Garcia was VP of US commercial operations and new product development at Aspreva Pharmaceuticals.

More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Freelance Account Manager / Senior Account Manager - Medical Edu...: £300 per day

Programme Director, Healthcare PR, Highly competitive package: Highly Competitive package

Associate Editorial Director – Med Comms – London: Salary TBC

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Senior Account Manager- Central Oxford and Abingdon: Negotiable

Account Director: Excellent benefits

Associate Director: £75, 000-90, 000

Medical Writers Required – Cheshire: DOE

Project / Account Manager (Medical Education): Salary TBC

Consultant Health Economics - London / Oxford: Negotiable

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Senior Account Executive, London, Medical Communications: Excellent package

Senior Account Managers - Oxfordshire: Attractive salary and benefits package offered

Account Director: £48, 000 - £60, 000

Associate Medical Director: Highly Competitive

Senior Medical Writer: Competitive Salary

Scientific Director / Editorial Team Leader: Great salary and benefits

Senior Medical Writer (Remote Working): Competitive Salary Offered

Leadership opportunity, Pricing & Market Access, UK, Substan...: Substantial six figure package

Production Manager – Healthcare Communications: DOE

Account Manager, Healthcare Communications: £32, 000 - £40, 000 bonus benefits

Consumer Health Account Director: Circa £60, 000 Gym and More

Medical Writers: Competitive Salary and Benefits

Director, Market Access / HEOR - North-West: Negotiable

Medical/ Scientific Director: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

emotive.

emotive. is an award-winning healthcare communications agency working with leading global and EMEA companies in life sciences including medical device...

Latest intelligence

World Diabetes Day: Interaction and impact of diabetes on mental health: For World Diabetes Day on the 14th November 2018, Nisha Shahrukh - Medical Writer at Mednet Group has written an article depicting the impact diabetes has on mental health. Including...
Innovation in merger control and the impact on the pharmaceutical sector: Is focusing on pipeline products enough to assess regulatory risks?...
Nudge-nudge, think-think: Chris Ross examines the personal complexities of human behaviour – and explains why fun, emotion and peer endorsement could be key to designing effective behavioural change programmes...